![](/img/cover-not-exists.png)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., Buggy, J. J.Volume:
107
Language:
english
Journal:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.1004594107
Date:
July, 2010
File:
PDF, 1.00 MB
english, 2010